Column Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Column Group’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,626,631	Closed	-$88.8M	–	8
2021 Q2	$88.8M	Hold	2,626,631	–	–	12.57%	4
2021 Q1	$61.4M	Hold	2,626,631	–	–	5.89%	6
2020 Q4	$75.6M	Buy	+2,626,631	New	+$66.1M	6.86%	6

Column Group's CNST Position: Q3 2021 in Review

Column Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 2,626,631 shares — an estimated $88.8M sold.

Column Group first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $88.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Column Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Column Group sold 2,626,631 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $88.8M.
Column Group first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
Column Group's Constellation Pharmaceuticals, Inc. position peaked at $88.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Column Group's 13F filing for Q3 2021, filed 12 Nov 2021.